| Promises, pitfalls and practicalities of prenatal whole exome sequencing |
40 |
| Maternal complications following open and fetoscopic fetal surgery: A systematic review and meta-analysis |
19 |
| Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing |
16 |
| Delivering an accredited non-invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice |
16 |
| ACOG and SMFM guidelines for prenatal diagnosis: Is karyotyping really sufficient? |
16 |
| Expanded carrier screening for monogenic disorders: where are we now? |
15 |
| Proposal for standardized prenatal ultrasound assessment of the fetus with congenital diaphragmatic hernia by the European reference network on rare inherited and congenital anomalies (ERNICA) |
14 |
| The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization |
13 |
| Diagnosis of lethal or prenatal-onset autosomal recessive disorders by parental exome sequencing |
13 |
| Zika virus during pregnancy: From maternal exposure to congenital Zika virus syndrome |
12 |
| Opening Pandora's box?: ethical issues in prenatal whole genome and exome sequencing |
12 |
| Fetal phenotypes emerge as genetic technologies become robust |
12 |
| Advanced paternal age, infertility, and reproductive risks: A review of the literature |
11 |
| Reliable detection of subchromosomal deletions and duplications using cell-based noninvasive prenatal testing |
11 |
| Prenatal DNA Sequencing: Clinical, Counseling, and Diagnostic Laboratory Considerations |
10 |
| Clinical experience with sex chromosome aneuploidies detected by noninvasive prenatal testing (NIPT): Accuracy and patient decision-making |
10 |
| Reproducibility of fetal lung-to-head ratio in left diaphragmatic hernia across the North American Fetal Therapy Network (NAFTNet) |
9 |
| The association between maternal methylenetetrahydrofolate reductase C677T and A1298C polymorphism and birth defects and adverse pregnancy outcomes |
9 |
| The Belgian MicroArray Prenatal (BEMAPRE) database: A systematic nationwide repository of fetal genomic aberrations |
9 |
| cfDNA screening and diagnosis of monogenic disorders - where are we heading? |
8 |
| A study to assess global availability of fetal surgery for myelomeningocele |
8 |
| Perinatal outcomes following cell-free DNA screening in > 32 000 women: Clinical follow-up data from a single tertiary center |
8 |
| Rare autosomal trisomies: Important and not so rare |
8 |
| Prenatal diagnosis of skeletal dysplasias using a targeted skeletal gene panel |
8 |
| Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome-wide sequencing for fetal diagnosis |
8 |
| Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT |
8 |
| Fetal arthrogryposis multiplex congenita/fetal akinesia deformation sequence (FADS)-Aetiology, diagnosis, and management |
7 |
| Diagnostic accuracy and clinical outcomes associated with prenatal diagnosis of fetal absent cavum septi pellucidi |
7 |
| Maternal liver transplant: Another cause of discordant fetal sex determination using cell-free DNA |
6 |
| Pandora's pregnancy: NIPT, CMA, and genome sequencing-A new era for prenatal genetic testing |
6 |
| A system-based approach to the genetic etiologies of non-immune hydrops fetalis |
6 |
| Chromosomal microarray analysis on uncultured chorionic villus sampling can be complicated by confined placental mosaicism for aneuploidy and microdeletions |
6 |
| Ethical and counseling challenges in prenatal exome sequencing |
6 |
| Prenatally diagnosed developmental abnormalities of the central nervous system and genetic syndromes: A practical review |
5 |
| Impact of prenatal diagnosis of complex congenital heart disease on neonatal and infant morbidity and mortality |
5 |
| Noninvasive reconstruction of placental methylome from maternal plasma DNA: Potential for prenatal testing and monitoring |
5 |
| Amniotic membrane and placental histopathological findings after open and fetoscopic prenatal neural tube defect repair |
5 |
| Spina bifida screening in the first trimester using ultrasound biparietal diameter measurement adjusted for crown-rump length or abdominal circumference |
5 |
| Clinical application of chromosomal microarray analysis for the prenatal diagnosis of chromosomal abnormalities and copy number variations in fetuses with congenital heart disease |
5 |
| Population-based trends in the prenatal diagnosis of sex chromosome aneuploidy before and after non-invasive prenatal testing |
5 |
| The association between severe fetal congenital heart defects and placental vascular malperfusion lesions |
5 |
| Impacts of variants of uncertain significance on parental perceptions of children after prenatal chromosome microarray testing |
5 |
| Parental perceptions of prenatal whole exome sequencing (PPPWES) study |
5 |
| Genetic profile of isolated congenital diaphragmatic hernia revealed by targeted next-generation sequencing |
5 |
| A sonographic approach to the prenatal diagnosis of skeletal dysplasias |
5 |
| Safety and efficacy of fetal surgery techniques to close a spina bifida defect in the fetal lamb model: A systematic review |
5 |
| Expanded carrier screening for autosomal recessive conditions in health care: Arguments for a couple-based approach and examination of couples' views |
4 |
| Prenatal diagnosis of posterior fossa anomalies: Additional value of chromosomal microarray analysis in fetuses with cerebellar hypoplasia |
4 |
| Comparison of umbilical cord occlusion methods: Radiofrequency ablation versus laser photocoagulation |
4 |
| Characterizing cardiac dysfunction in fetuses with left congenital diaphragmatic hernia |
4 |
